Ads
related to: causative agent of pyelonephritis treatment- Dosing and Administration
Access Info About Dosing and
Administration Here.
- Adverse Reactions
Find Adverse Reactions and
Important Safety Information Here.
- Read FAQs
See Frequently Asked Questions
for a Treatment Option.
- Mechanism of Action
Find MOA Information for
an Available Treatment Option.
- Dosing and Administration
Search results
Results From The WOW.Com Content Network
Treatment of xanthogranulomatous pyelonephritis involves antibiotics as well as surgery. Removal of the kidney is the best surgical treatment in the overwhelming majority of cases, although polar resection (partial nephrectomy) has been effective for some people with localized disease.
Fosfomycin can be used as an effective treatment for both UTIs and complicated UTIs including acute pyelonephritis. [87] The standard regimen for complicated UTIs is an oral 3g dose administered once every 48 or 72 hours for a total of 3 doses or a 6 grams every 8 hours for 7 days to 14 days when fosfomycin is given in IV form. [87]
Urinary anti-infective agent, also known as urinary antiseptic, is medication that can eliminate microorganisms causing urinary tract infection (UTI). UTI can be categorized into two primary types: cystitis , which refers to lower urinary tract or bladder infection, and pyelonephritis , which indicates upper urinary tract or kidney infection. [ 1 ]
pyelonephritis. Those with urogenital or extragenital infections caused by M. hominis have symptoms similar to other sexually transmitted infections and its presence cannot be determined by its symptoms. The precise role this organism plays in causing disease remains speculative. [4]
Acute proliferative glomerulonephritis is a disorder of the small blood vessels of the kidney.It is a common complication of bacterial infections, typically skin infection by Streptococcus bacteria types 12, 4 and 1 but also after streptococcal pharyngitis, for which it is also known as postinfectious glomerulonephritis (PIGN) or poststreptococcal glomerulonephritis (PSGN). [4]
Together with intravenous antibiotics, drainage [8] —either percutaneous or retrograde with a ureteral stent [9] —has become the cornerstone of treatment since the development of ultrasonography and computed tomography (CT) scanning. Drainage offers a great outcome with low rates of morbidity and mortality.